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O ut-of-hospital cardiac arrest (OHCA) is an important public health problem affecting at least 390 000 people per year in North America alone.
1 Professional organizations including the International Liaison Committee on Resuscitation, and the American Heart Association, as well, recommend epinephrine as the first-line drug treatment for OHCA. 2 Epinephrine improved the rate of return of spontaneous circulation (ROSC) in 2 small randomized trials including patients with both shockable and nonshockable rhythms. 3, 4 Several observational studies have demonstrated that the effects of epinephrine may be time dependent, with earlier epinephrine associated with improved outcomes in OHCA with shockable initial cardiac rhythms. [5] [6] [7] However, the majority of patients with OHCA present with nonshockable initial cardiac rhythms where epinephrine and advanced airway management are the primary advanced life support (ALS) interventions available to emergency medical services (EMS). However, the ideal timing of epinephrine administration is unclear. One observational study in Japan reported that among witnessed arrests with pulseless electric activity (PEA), epinephrine given before 20 minutes was associated with improved survival, but the optimal time for delivery was not explored, and these findings may also not be generalizable to other EMS systems. 8 Epinephrine is thought to benefit patients in cardiac arrest by increasing coronary perfusion pressure potentially enhancing cardiac function, but may also reduce cerebral flow and can cause increased myocardial oxygen demand. 9, 10 The timing of drug delivery in relationship to the onset of the arrest may affect the balance of the potential benefits or harms of epinephrine.
The objective of this study is to evaluate the association between timing of the first dose of epinephrine and survival to hospital discharge among patients with OHCA who have initial nonshockable rhythms. Our primary hypothesis was that delays in epinephrine administration would be associated with decreased odds of survival.
METHODS
The data from this study will be made available publicly through the NHLBI Biological Specimen and Data Repository Information Coordinating Center, with anticipated release in 2018. Institutional review board/ethics approval was obtained from all study sites, and waivers of consent were granted for study subjects.
Study Setting
The Resuscitation Outcomes Consortium (ROC) research network includes 10 sites in North America (7 in the United States and 3 in Canada), 260 EMS agencies, and 287 participating hospitals, serving a combined population of ≈24 million people. 11 The network was created to study the treatment and outcomes of patients with cardiac arrest and severe traumatic injuries focusing on interventions that take place in the out-ofhospital setting. The ROC Epistry is a prospective epidemiological registry of consecutive patients with OHCA in the network for whom there is an organized EMS response. To be enrolled in the Epistry, patients must receive chest compressions by EMS personnel or defibrillation by EMS or bystanders, including use of an automated external defibrillator. Data collection for the ROC Epistry was approved by the institutional review board or research ethics boards at each participating site.
Study Population
In this analysis, we included EMS-treated patients of all ages from June 4, 2011 to June 30, 2015 with OHCA presenting with initial nonshockable rhythms defined as PEA or asystole. We excluded patients who had epinephrine administered but were missing the timing of administration, those who had received epinephrine before an EMS-witnessed arrest, and those who received epinephrine after a rearrest following initial ROSC without epinephrine. We also excluded patients who achieved early ROSC, defined as within 10 minutes of arrival of the first EMS agency specifically to mitigate bias caused by including patients resuscitated successfully before epinephrine could feasibly be delivered. Patients with initial nonshockable rhythms who did not receive any epinephrine were not included in the primary sample, but were included in a sensitivity analysis. We included patients in the primary analysis regardless of whether or not complete
Clinical Perspective
What Is New?
• This study finds that in both adults and children with out-of-hospital cardiac arrest from a nonshockable initial rhythm, faster time from arrival of emergency medical services providers to the first dose of epinephrine is associated with improved survival.
• Each minute delay was associated with worsened odds of survival to discharge and neurologically intact survival in continuous analysis of time to epinephrine delivery.
• In a categorical analysis, epinephrine delivery in <10 minutes was also associated with significantly improved odds of survival.
What Are the Clinical Implications?
• At present, the majority of initial doses of epinephrine are delivered >10 minutes from emergency medical services arrival for patients with out-ofhospital cardiac arrest with initial nonshockable rhythms.
• However, initial epinephrine dosing in <10 minutes is associated with significantly improved survival.
• Providers should consider ways to deliver epinephrine as early as feasible during resuscitation for outof-hospital cardiac arrest with initial nonshockable rhythms.
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cardiopulmonary resuscitation (CPR) process files were available, because CPR process measurement varies by monitor manufacturer. CPR process files contain data collected by the electronic patient monitor in conjunction with an attached CPR accelerometer and allow measurement of chest compression rate, depth, and fraction (percent of resuscitation in which CPR was being performed).
Data Quality
The 10 sites used several strategies to identify the cardiac arrest cases including electronic queries of EMS records, manual sorting of paper EMS charts, and telephone notification of each treated patient by EMS personnel. 12 After incident cases were identified, trained research assistants at each site abstracted data into a standardized electronic database managed by the network. Each site developed specific data quality assurance processes, including training of the EMS providers in data collection, variable definitions, and review of randomly selected records for data quality both by the site and by the network clinical coordinating center. Multiple logic checks on the data were also included in the electronic data entry and transmission processes. The data-coordinating center conducted annual audits of random charts from each site including EMS and hospital data both remotely and in person, allowing sites to ensure high data quality and make improvements to data abstraction as needed. The ROC Epistry registry was used to collect EMS and outcomes data for all ROC clinical trials.
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Main Exposures and Outcomes
The primary exposure was time in minutes from the first EMS agency arrival on the scene to the first administration of epinephrine. The ROC data abstraction form records timing and dose of each medication. In addition to the minute-by-minute classification, we dichotomized the epinephrine administration on the basis of who received initial epinephrine early (defined as <10 minutes) versus late (defined as ≥10 minutes), consistent with time-group classification used in the published studies on shockable rhythms. 
Outcome
The primary outcome for this study was survival to hospital discharge. Although neurological status at discharge was not recorded for all cases, a subset of patients in the registry was included in a randomized trial of CPR in OHCA and neurological outcomes were ascertained in this group. 15 We performed a subgroup analysis of patients from this trial defining a favorable neurological outcome as modified Rankin Scale <3 (slight disability or better) (modified Rankin Scale range: 0-6; 0 = no symptoms, 6 = death).
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Covariates
We categorized the presenting rhythm as ventricular fibrillation/ventricular tachycardia, PEA, asystole, not shockable without available rhythm strip (automated external defibrillator only), and cannot determine. We grouped together PEA, asystole, and nonshockable rhythms for this analysis. Other covariates in logistic regression analysis are detailed below.
Statistical Analysis
We used descriptive statistics to characterize groups by timing of epinephrine administration. Survival to hospital discharge proportions were examined at 1-minute intervals.
To examine the relationship between survival and epinephrine timing, we evaluated epinephrine timing as a continuous variable in multivariate logistic regression models adjusted for age (years); sex; witness status (EMS/bystander/none); bystander CPR (yes/no); initial rhythm (PEA/asystole); time from dispatch to first EMS arrival (minutes); vascular access success (intravenous [IV]/intraosseous [IO]/both/neither); successfully placed advanced airway (endotracheal intubation/ laryngeal tube/both/none); arrest location (public/private); etiology of arrest (cardiac/noncardiac); and ROC site. Successful advanced airway was defined as an airway for which placement was confirmed by EMS per local protocols. We could not account for airway device attempts, removal, or abandonment of the device while in the field because these were not required data points. We planned a similar analysis for the pediatric patients (<18 years of age) using the same exposure, outcomes, and covariates.
We conducted a series of sensitivity analyses to evaluate the robustness of the relationship between epinephrine timing and survival. For early versus late epinephrine, we conducted a sensitivity analysis that included patients not administered epinephrine as part of the late administration group. For continuous time to epinephrine, we conducted additional sensitivity analyses using the time from arrival of the first ALS-capable agency on the scene (sensitivity A), and time from EMS dispatch to epinephrine (sensitivity B) as the exposures. In a third sensitivity analysis (sensitivity C), we eliminated the exclusion criterion of ROSC in <10 minutes and included all patients who had received epinephrine. In addition, we performed an analysis in the cohort of patients who had CPR process measures available including chest compression fraction (percentage of time compressions were being performed during resuscitation), average chest compression depth, chest compression rate (100-120, <100, or >120 per minute) (sensitivity D). We performed several subgroup analyses by including interaction terms in the full models for early versus late epinephrine. We assessed interactions for early versus late epinephrine with chest compression fraction (<0.8 versus ≥ 0.8), rate (100-120 versus <100 or >120), depth (37-51 mm versus <31 or >51 mm), PEA versus asystole initial rhythms, and witnessed versus unwitnessed arrests. Arrests with missing or unknown covariate data were excluded from all analyses. For the pediatric subgroups, we assessed age by subcategories of 0 to 1 year, 1 to 11 years, and 11 to 18 years. We conducted an additional analysis that included those with ROSC in <10 minutes. Previous data have demonstrated differences in epinephrine administration between and within ROC EMS agencies. In addition, to account for potential differences between EMS agencies, rather than study site that encompassed multiple agencies, we conducted a separate analysis using generalized estimating equations to control for clustering at the EMS agency.
We analyzed separate models using a categorical term for epinephrine timing, splines for epinephrine timing, and an indicator that epinephrine was administered before or after successful airway application. Last, we plotted adjusted survival probabilities for epinephrine times between 0 and 20 minutes. Using the fitted model, we set covariate values to represent the average patient in the sample and then systematically varied epinephrine timing. We conducted all analyses using S-Plus version 6.2.1 (TIBCO Software Inc.) and Stata version 11 (StataCorp).
RESULTS
From 55 568 EMS-treated cardiac arrests, we excluded 17 620 with shockable rhythms. We then excluded 2271 because of the population definitions noted above and 1643 because of missing epinephrine timing data (Figure 1) . After applying all exclusions, the sample of patients who received epinephrine by EMS consisted of 26 755 patients. With the use of the 10-minute cutoff for time from first EMS arrival to epinephrine administration, the final population included 12 238 in the early group and 14 417 in the late group. Patient characteristics are shown in Table 1 . The early and late epinephrine groups were similar, although EMS-witnessed arrests were twice as likely to receive epinephrine early. Among patients receiving epinephrine, the majority received epinephrine >10 minutes from EMS arrival (54.2%).
Unadjusted Outcomes
Overall, unadjusted survival to discharge was 2.6% in the early group and 1.7% in the late group. For patients with initial PEA, unadjusted survival was 4.9% in the early group and 4.8% in the late group. For patients with initial asystole, unadjusted survival was 1.5% in the early group and 1.0% in the late group. In Figure 2 , we display the unadjusted survival to hospital discharge using 2-minute intervals of time from EMS arrival to epinephrine administration. The highest survival was noted when epinephrine was given before 4 minutes, which occurred in 7% of patients.
Adjusted Outcomes
After adjusting for potential confounders, each additional minute of time from EMS arrival to epinephrine administration was associated with 4% decrease in the odds of survival to hospital discharge (odds ratio [OR], 0.96; 95% confidence interval [CI], 0.95-0.98) ( Table 2 ). The results of 4 sensitivity analyses are also displayed in Table 2 and demonstrate similar results. When epinephrine was given late versus early, the odds of survival decreased 18% (OR, 0.82; 95% CI, 0.68-0.98), and this result was stable when those who were not given epinephrine were included in the late group. In Figure 3 , we plot the covariate adjusted expected probability of survival to discharge with varying epinephrine administration times and demonstrate that the highest survival was when epinephrine is given within 10 minutes of EMS arrival. In the analysis that included patients who received epinephrine and had ROSC in <10 minutes, the results favored early epinephrine with larger effect sizes than those in the primary analysis (continuous analysis OR, 0.93; 95% CI, 0.91-0.95; categorical analysis OR, 0.61; 95% CI, 0.52-0.71). In the generalized estimating equations analysis in which we controlled for clustering by each EMS agency, rather than study site, we found similar results in the direction and significance to the primary continuous and early versus late analyses (continuous analysis OR, 0.95; 95% CI, 0.93-0.97; categorical analysis OR, 0.67; 95% CI, 0.57-0.79).
We found a significant interaction between early versus late epinephrine and arrest witness status (P=0.02). In an exploratory subgroup analysis of witnessed versus unwitnessed arrests, late epinephrine was significantly associated with lower odds of survival in comparison with early epinephrine in unwitnessed arrests (OR, 0.63; 95% CI, 0.48-0.83), but there was no association in the witnessed arrest group (OR, 0.93; 95% CI, 0.75-1.14). Similarly, we found a significant interaction between early versus late epinephrine and initial rhythm. In an exploratory subgroup analysis of PEA versus asystole, late epinephrine was significantly associated with lower odds of survival in asystole in comparison with early epinephrine (OR, 0.62; 95% CI, 0.47-0.81), but there was no association in the PEA group (OR, 0.96; 95% CI, 0.77-1. 19 ). The CPR process variable interaction terms were not statistically significant.
Epinephrine was administered via the IV route 70% of the time in adults, whereas it was given via the IO route 71% of the time in children. After adjustment for other covariates, in both the primary adult and pediatric models, the route of epinephrine administration was not significantly associated with survival.
Neurological Outcomes
In the subgroup analysis of 13 290 patients from the randomized trial requiring neurological outcome determination, odds of survival with modified Rankin Scale <3 were reduced 6% (OR, 0.94; 95% CI, 0.89-0.98) for each minute delay in epinephrine administration.
Pediatric Analysis
In the 595 pediatric patients, odds of survival were decreased 9% (OR, 0.91; 95% CI, 0.81-1.01) for each minute delay in epinephrine administration. Odds of survival were decreased 57% (OR, 0.43; 95% CI, 0.16-1.14) when epinephrine was given late in comparison with early. Results were similar when chil- Values indicate n (%) unless otherwise indicated.
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dren who were not given epinephrine were included in the late group.
DISCUSSION
In this North American observational study of 26 755 adults and children with OHCA and initial nonshockable rhythms, each minute of delay to epinephrine delivery was associated with reduced survival to hospital discharge after controlling for multiple known confounders. In a subgroup analysis, we also found that each minute delay in epinephrine was also associated with worsened neurological outcome. Overall, our results suggest that earlier administration of epinephrine may improve the probability of neurologically intact survival in patients with nonshockable initial rhythms. The association between time to epinephrine and survival was stable across several sensitivity analyses. The association between timing of epinephrine administration and survival was modified by witness status and initial rhythm. Results were similar for pediatric patients, although the smaller sample size may have contributed to the lack of statistical significance. Together, these results suggest that, in nonshockable rhythms, it may be important to focus on delivering epinephrine earlier during the course of resuscitation. The results of this study are similar to those of Ewy et al 7 who assessed the effect of time from dispatch to epinephrine administration on 3469 patients in Arizona with witnessed arrests, 42% of whom had an initial shockable rhythm. The odds ratio for survival to hospital discharge for each minute delay in epinephrine administration was 0.95, although this was only significant in patients with initial shockable rhythms. 7 Recent studies of in-hospital cardiac arrests, 2 in adults and another in pediatric patients, found that shorter times to first epinephrine were also associated with improved survival. [17] [18] [19] Our study adds to the scientific body supporting early epinephrine administration by demonstrating the importance of early epinephrine in nonshockable initial OHCA rhythms, including asystolic and unwitnessed arrests, in a large and geographically diverse patient cohort.
Previous studies have consistently found that epinephrine improves the rate of ROSC during cardiac arrest. [3] [4] [5] 20, 21 The primary physiological mechanism for improving ROSC is thought to be through the α-effect of epinephrine improving aortic diastolic pressure, which leads to an increase in blood flow to the left ventricle mediated by an increase in coronary perfusion pressure. [22] [23] [24] [25] However, vital organs such as the brain and heart become more ischemic with longer CPR times, and the beneficial effects of epinephrine on left ventricular blood flow may be countered by a reduction in cerebral blood flow, worsened brain ischemia, reduced microcirculatory flow, and increased myocardial oxygen demand. 9, 10, 26 We found that more than half of the patients in this study received epinephrine >10 minutes from the first EMS arrival, although there was significant variability across the sites. Our findings suggest that a focus on earlier epinephrine administration in patients with nonshockable initial cardiac rhythms is feasible, because some sites have successfully accomplished this. Furthermore, earlier epinephrine administration may also improve neurological outcomes in these patients. Although overall survival from OHCA with nonshockable initial rhythms is poor, these rhythms are initially present in the majority of patients with OHCA, so small increases in survival rates could have a significant public health impact. 
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We also found that, in adults, epinephrine was given via the IV route 70% of the time, whereas it was given via the IO route in pediatric patients 71% of the time. There was no association between route of administration of epinephrine and survival. Using a powered device, providers are able to achieve IO access with >95% success in <30 seconds, after undergoing minimal training. 27 At present, vascular access procedures and IV medications, in general, are ALS procedures, which may be a limiting factor in time to epinephrine delivery in certain EMS systems. Incorporating IO vascular access and epinephrine administration into basic life support training could improve epinephrine delivery times in some EMS systems. However, it is unknown in human cardiac arrest if the pharmacokinetics of epinephrine are the same when using the IV and various IO routes (eg, proximal tibia versus proximal humerus), and this should be a consideration for future studies. 28 
Limitations
This was a secondary analysis of a cardiac arrest registry, and thus we are only able to comment on association rather than causation. There is the potential for residual confounding, because previous research has shown that traditional Utstein variables do not completely explain the variability in outcomes after OHCA. 29 Earlier epinephrine administration may also be a marker for higher quality ALS care overall. Controlling for study site in the primary models, and for agency in the generalized estimating equations analysis in an effort to reduce confounding attributable to differences in EMS care and patient populations, did not change our findings. Although reassuring, these analyses may not fully account for ALS care variability within individual EMS agencies. 30 Although the ROC sites are geographically diverse, they represent mature, high-functioning EMS systems that may not be completely generalizable, especially to EMS systems outside North America.
We were also unable to assess the specific aspects of postresuscitation hospital care (eg, targeted temperature management and early coronary angiography) that can impact patient outcomes, although these factors seem less likely to be associated with time to epinephrine administration and are most notable among patients with an initial rhythm of ventricular fibrillation/ tachycardia.
CONCLUSIONS
We found an association between each minute delay in epinephrine administration and decreased survival to hospital discharge, and survival, as well, with favorable neurological outcomes in adult and pediatric patients with nonshockable OHCA. EMS agencies should consider prioritizing early administration of epinephrine among patients presenting with PEA or asystole in their training and protocols. 
